What does the evidence say about Nutritional Yeast Fatigue Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Nutritional Yeast Fatigue Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - However, clinical evidence linking their intake to site-specific upper respiratory mucosal immune health in humans remains limited. [Kanno T (2026); evidence level 2] - SC-BG intake also attenuated declines in s-IgA levels in the posterior oropharyngeal wall and nasopharynx and increased salivary lysozyme concentrations. [Kanno T (2026); evidence level 2] - Background/Objective : Dietary polysaccharides are increasingly recognized as functional nutritional components that support human health through modulation of immune function. [Kanno T (2026); evidence level 2] - It also critically evaluates the current level of evidence and highlights key limitations related to standardization, variability of extracts, and clinical applicability. [Sadowska Anna (2026); evidence level 3] - Notably, a fungus calledwas found among the belongings of the world’s oldest human mummy, estimated to be about 4000 years old. [Sadowska Anna (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.